Abstract：Objective To observed the clinical effect of self-proposed Shenfu Zhenqi Tang combined with rivaroxaban in treating chronic heart failure. Methods 80 patients with chronic heart failure were randomly divided into the control group and the observation group, and the control group received conventional treatment + rivaroxaban treatment. The observation group received conventional treatment + rivaroxaban. The observation group was treated with self-proposed Shenfu Zhenqi Tang based on the control group. The two groups were compared regarding improvement of major clinical symptoms, serum NT-pro BNP level, 6-min walking distance, improvement of cardiac function, and therapeutic effect. Results The disappearance time of clinical symptoms such as palpitation and shortness of breath in the observation group was shorter than in the control group. There was no statistically significant difference between the two groups in the disappearance time of clinical symptoms such as facial limb swelling, dry mouth, shortness of breath, chest tightness, and cough. The serum NT-pro BNP level after treatment in the observation group was lower than that in the control group. The 6-minute walking distance after treatment in the observation group was much longer than that in the control group. After treatment, LVESD, LVEDD, and LVRT of the observation group were significantly lower than those of the control group, and EF was significantly higher than that of the control group. The total effective rate after treatment in the observation group was higher than in the control group. Conclusion Self-designed Shenfu Zhenqi Tang combined with rivaroxaban in treating of chronic heart failure can reduce clinical symptoms, lower plasma NT-pro BNP level, increase 6-minute walking distance, improve myocardial function, and be suitable for clinical application.
郭晓阳, 何岳, 邓小秀, 潘庆登, 包蕙先. 自拟参附贞芪汤联合利伐沙班治疗慢性心衰的临床疗效研究[J]. 湖南师范大学学报(医学版), 2023, 20(6): 70-72.
GUO Xiaoyang, HE Yue, DENG Xiaoxiu, PAN Qingdeng, BAO Huixian. Study on the clinical effect of self-proposed Shenfu Zhenqi Tang combined with rivaroxaban in the treatment of chronic heart failure. HuNan ShiFan DaXue XueBao(YiXueBan), 2023, 20(6): 70-72.
2023, Vol. 20 
